1 Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 5-й выпуск. Сахарный диабет. 2011; 3 (Прил.): 4–72.
2. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 6-й выпуск. Под ред. И.И.Дедова, М.В.Шестаковой. М., 2013. 
3. Bril V, England J, Franklin G et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76: 1758–65.
4. Tesfaye S, Vileikyte L, Rayman G et al. Toronto Expert Panel on Diabetic Neuropathy. Painful Diabetic Peripheral Neuropathy: Consensus Recommendations on Diagnosis, Assessment and Management. Diabetes/Metabolism Research and Reviews 2011; 27: 629–38.
5. Vinik A, Casellini C. Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013; 6: 57–78.
6. Shakher J, Stevens M. Update on the management of diabetic polyneuropathies. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011; 4: 289–305.
7. Boyle J, Eriksson M, Gribble M et al. Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain. Diabetes Care 2012; 35: 2451–8.
8. Tanenberg R, Irving G, Risser R et al. Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison. Mayo Clin Proc 2011; 86: 615–24.
9. Johnston S, Udall M, Cappelleri J et al. Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine. Am J Health Syst Pharm 2013; 70: 2207–17.
10. Toth C. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Medicine 2010; 11: 456–65.
11. Tolle T, Xu X, Sadosky A. Painful diabetic neuropathy: cross-sectional survey of health state impairment and treatment patterns. J Diab Compl 2006; 20: 26–33.
12. Cruccu G, Attal N. Do clinicians adhere to treatment recommendations for neuropathic pain? Pain 2012; 153: 740–1.
13. Hall G, Morant S, Carroll D et al. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Family Practice. 2013; 14: 28–38.
14. Хуторная О.Е., Бреговский В.Б., Демина А.Г. и др. Выбор терапии болевых форм диабетической полинейропатии нижних конечностей: традиционная концепция или индивидуализированный подход? Cons. Med. 2012; 14 (12): 42–5.
15. Хуторная О.Е., Бреговский В.Б., Демина А.Г. и др. Частота выявления болевых форм диабетической полиневропатии в амбулаторных условиях и анализ эффективности их лечения. Тезисы 6 Всероссийского диабетологического конгресса. 2013; 166–7.
16. Oyibo S, Prasad Y, Jackson N et al. The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002; 19: 870–3.
17. Chaparro L, Wiffen P, Moore R et al. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012; 7: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008943.pub2/full.
18. Gilron I, Bailey J, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352: 1324–34.
19. Gilron I, Bailey J, Tu D et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374 (9697): 1252–61.
20. Tesfaye S, Wilhelm S, Lledo A et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The «COMBO-DN study» – a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 2013; 154: 2616–25.
21. Boulton A, Freeman R, D’Urso De Cruz. Are patient characteristics predictive of a response to pregabalin? Analysis from 5 randomized, placebo-controlled trials in painful diabetic peripheral neuropathy. Diabetologia 2006; 49 (Suppl. 1): 668–9.
22. Vinik A, Emir B, Parsons B et al. Prediction of Pregabalin-Mediated Pain Response by Severity of Sleep Disturbance in Patients with Painful Diabetic Neuropathy and Post-Herpetic Neuralgia. Pain Med 2013. Epub ahead of print. http://www.ncbi.nlm.nih.gov/pubmed/24330406
23. Бреговский В.Б., Посохина О.В., Карпова И.А. Предикторы эффективности лечения диабетической полинейропатии нижних конечностей альфа-липоевой кислотой. Терапевт. арх. 2005; 10: 15–9.
24. Храмилин В.Н., Демидова И.Ю., Игнатова О.Ю. Оценка эффективности различных режимов пероральной терапии альфа-липоевой кислотой болевой формы диабетической периферической полинейропатии. Сахарный диабет. 2010; 2: 28–32.
25. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocr and Metab 2005; 90: 4936–45.
26. Magrinelli F, Zanette G, Tamburin S. Neuropathic pain: diagnosis and treatment. Rev Pract Neurol 2013; 13: 292–307.
27. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113–88.

В.Б.Бреговский

ФГБУ Федеральный медицинский исследовательский центр им. В.А.Алмазова, Санкт-Петербург; 
Территориальный диабетологический центр СПб ГБУЗ ГКДЦ №1